|
Teva: The 800-pound gorilla of generics
2008-06-06 07:00:00 "Analysts estimate that the worldwide market for generic drugs will increase from $75 billion to $125 billion by 2012," says biotech sector expert Michael Shulman (http://www.thestockadvisors.co-m/ccount/click.php?id=2067).In- his ChangeWave Biotech Investor (http://www.thestockadvisors.co-m/ccount/click.php?id=2067) he states, "The key question for us is: Who is going to make the most money from these expirations? And the 800-pound gorilla in this market is our long-time holding, Teva Pharmaceuticals (http://www.thestockadvisors.co-m/quote.htm?sym=teva) (NASDAQ: TEVA (http://www.thestockadvisors.co-m/quote.htm?sym=teva))."Teva is the largest and best generics company in the world with $9.4 billion in sales in 2007 and the gap between it and its competitors is growing. Teva has 331 products on the market, 65% more than its closest competitor. "More importantly, based on its business model of a mix of proprietary and generic drugs, the company's operating margins are 10 points higher ...
Generics
2008-06-03 20:42:00 Personally, I think that most of the time the generic brands are just as good as the name brands. Most of the time you are just paying for the name and t hat is it…all the ingredients are exactly the same. However you want to make sure that you get the quality generic ... This is a content summary only. Visit my website for full links, other content, and more!
Generics: just as good?
2008-03-15 03:15:00 IN the contentious debate over insuring Americans' health, the value of generic prescription drugs is a rare point of consensus. Patients, physicians, employers, politicians -- all hail generics as powerful treatment for a swelling healthcare tab.
By: Get rich
Brand name prescription drugs or the generics?
2008-03-09 13:20:00 Over the generic drugs, I personally choose brand name prescription drugs. True, the generics are priced way cheaper than the branded ones, but to me the higher the price and the more trusted the drug name or its company, the more it matters, even as they say they have just the same effect. It is just that I am quite cautious of many unbranded drugs that been sold left and right everywhere. I [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Sexual Addiction and Generics
2008-02-14 01:42:00 Are addicted to aliment drugs, booze and cannot endure without these things.Some people are addicted to screwing These people cannot endure without screwing having it away has been associated with the fulfilling of mythical pleasure Normally, screwing is an phrasing of pleasure and solicit in behalf of one???s friend degree in behalf of screwing addicts screwing is a craving.Having it away addicts do not be aware words like pleasure benefit of them screwing is a crisis which needs to satisfied prosaic They spurn impotency drugs like generic Cialis and generic Viagra to amplify their libido.Medicines like and is Euphemistic pre-owned to premium individuals with erectile dysfunction.Sex maniacs spurn them to to boot increase their erection.Viagra, the brief chap-fallen was nothing but a tool in behalf of the richie heavy now with theing of the generics, more than ever notwithstanding themon clap in irons is bing a screwing devotee having it away addicts are everlastingly at a jeopardy...
By: medicine news
Why many—most?—doctors don’t like generics
2008-02-04 05:03:00 By Sherryl Anne G. Quito, Senior ReporterIs medicine manufacturing and distribution controlled by a multinational cartel? And why do many doctors—maybe most doctors—love it?Most pro-poor NGOs, like Kilos Bayan para sa Kalusugan (KSB), say “yes” to the first question and can easily explain the second.The passage of the Generics Law 20 years ago has not really made the most important generic medicines widely available and affordable to the poor, say KSB and its brethren NGOs.They think this is largely because the law has essentially merely led to the emergence of a two-tiered market, which is still controlled by the big drug companies. These companies merely produce for and market to both tiers and thereby profit from both generic and branded drugs.Generic drugs have limited penetration of the market’s distribution and retail systems. Both are dominated by the established pharmaceutical companies.For example, multinational companies import bulk drugs, 80 percent of which go ...
Are Generics OK for Industrial Apps?
2008-01-27 14:16:00 Everyone uses generic products in their daily lives, whether pharmaceuticals or paper towels. But most of us have resisted using generic products for industrial applications. A new venture called eConnek claims to provide low-priced generic alternatives to popular OEM electrical connectors, and comp
Generics and covariance/contravariance
2007-10-09 18:16:00 Today I was writing code that looks like this: public interface IChild<TParent> {} public class GenericSet<TChild> where TChild : IChild<GenericSet<TChild&-gt;> {} public class SpecificSet : GenericSet<ChildClass> {} public class ChildClass : IChild<SpecificSet> {} If you try to compile this you'll get the following compiler error: The type 'ChildClass' must be convertible to 'IChild<GenericSet<ChildC-lass>>' in order to use it as parameter 'TChild' in the generic type or method 'GenericSet<TChild>' Because ChildClass inherits from IChild<SpecificSet> and SpecificSet inherits from GenericSet<ChildClass> I assumed that this should work. Purely from an OO view ChildClass is a IChild<GenericSet<ChildCl-ass>> through inheritance. Unfortunately C# and other .net languages do not support covariance and/or contravariance (definition), Eiffel.net seems to be an exception. The CLR itself on the othe...
Convert Between Generic IEnumerable
2007-09-20 23:43:00 Generics in .NET 2.0 provides the ability to create strongly-typed collections in C#. Unfortunately, C# currently does not support generics variance, which would allow inheritance of generic types. For example, consider a list of strings and a list of objects: List<string> strings = new List<string>(); strings.Add( "hello" ); strings.Add( "goodbye" ); List<object> objects = new List<object>(); objects.AddRange( strings ); The final line ...
?Big Pharma? must plan ahead as patent expiries stimulate generics growth
2007-08-08 11:06:00 Recent figures show that the global generics market grew by 20% in 2005 ? three times the amount by which the pharma sector grew, and four times the growth of patented drugs. In fact, Cygnus predicts continued growth for the sector in the next five years, forecasting a CAGR of 13.62% for 2006-2010. Analysts have identified ...
OReilly Java Generics and Collections Oct. 2006
2007-06-28 10:37:00 This comprehensive guide shows you how to master the most important changes to Java since it was first released. Generics and the greatly expanded collection libraries have tremendously increased the power of Java 5 and Java 6. But they have also confused many developers who haven't known how to take advantage of these new features.Java Generics and Collections covers everything from the most basic uses of generics to the strangest corner cases. It teaches you everything you need to know about the collections libraries, so you'll always know which collection is appropriate for any given task, and how to use it.Download
Sanofi's Acomplia Flattened By Indian Generics
2007-05-29 18:28:00 Acomplia, which is still waiting for the FDA's approval to be sold in the United States, is dealing with stiff competition engendered by its generic versions
By: Rimonabant
Mylan to buy Merck Generics Unit
2007-05-13 13:32:00 Mylan Laboratories Inc. agreed to buy Merck KGaA's generic-drug unit for 4.9 billion euros ($6.7 billion) in cash to become the world's third-largest maker of generics.The acquisition will create a company with 2006 sales of about $4.2 billion. Mylan has arranged debt financing from Merrill Lynch & Co., Citigroup Inc. and Goldman Sachs Group, Inc. Mylan beat a rival bid by Teva, according to several people familiar with the transaction. Darmstadt, Germany-based Merck is selling the unit to pay down debt for its $13.7 billion acquisition of Serono SA. The purchase, the biggest in generics since Teva Pharmaceutical Industries Ltd.'s $7.6 billion takeover of U.S.- based Ivax Corp. in January 2006, brings to an end a four-month battle for the world's fourth-largest maker of generics. The price Mylan is paying is more than five times its own sales in the year ended March 2007 of $1.26 billion and more than its own market capitalization of $5.39 billion. The acquisition comes almos...
Merck Selling Generics Unit for $6.6B
2007-05-13 12:49:00 BERLIN -- German drug maker Merck KGaA announced Sunday that it is selling its generic drug business to Mylan Laboratories Inc. of the U.S. for euro4.
By: Get rich
An attempt was made to load a program with an incorrect format. (Exception
2007-03-22 07:17:00 Justin (Justin-Josef Angel) had reported a bug in .NET Generics where using a constraint for a Generic type of type 'class'.As He mentioned, when declaring the following, one will get a serious exception with hardly no way to Debug (BadImageFormatException).publi-c class SpecificClass: BaseClass: where T : class { }Justin claims that Microsoft, through MSDN, is directing software developers to use the class constraint. I'm trying to understand his problem; Is the problem is with having a constraint as general as 'class'.Reading the MSDN article he relies on (MSDN) I can see that developers are directed to use constraints on some occasions, however we are not directed to use the 'class' constraint in particular.I agree that there is no warning on this specific usage of the constraint, but I am not surewhy should we use such a General constraint at all.Links:Justin PostMSDN
By: Tal's Blog
Pharma- The biogenerics opportunity
2006-11-18 19:20:00 The 30-year-old biologicals industry is over $50 billion in size. At 15 per cent growth rate, it is also the fastest growing category of drugs in the global pharma market. Of course, conventional pharma, at $500 billion, is 10 times as big, but it is growing at about 8 per cent.Today, biologicals present another opportunity for Indian pharma ? in the form of biogenerics (also called biosimilars) or generic copies of biologicals.Here?s how. In the last few years, new filings of conventional drugs have shrunk. So, there are fewer drugs to make copies of. Stricter regulations, higher failure in clinical trials, and longer time taken for approval of generics are other dampeners. Meanwhile, development of new biologicals has been on the rise. Besides, biologicals worth $14 billion are expected to go off patent by 2010. While insulin and erythropoietin are already off patent, products like interferon (Schering-Plough, Biogen) and granulocyte colony stimulating factor or G-CSF (Amgen) are ...
Are Generics the Same As Brand Name Meds?
2006-02-16 00:59:00 An informed consumer is critical to ensure quality care. The mental health professional needs feedback from the client to ensure care is effective. That is as much true for counselors as it is for psychiatrists. Insurance companies and now Medical Assistance have been increasingly using medication "formularies" to control the cost of their medication budget. Formularies limit the choice of medication for which the insurance company will pay. Often that is because there are a choice between brand name and generic medications or a choice among a number of equivalent brand names. Formularies also limit access to newly developed medications that are considered "experimental." While there may be some notable exceptions, formularies exist primarily to save money. Insurance companies and generic medication manufacturers insist that generic are as high quality as name brands. The Federal Drug Administration (FDA) sets standards that say generics must be equivalent in quality and potency...
By: Dare To Dream
Three Indian Generics Beleaguered Sanofi's Acomplia
1970-01-01 00:59:00 Acomplia (Rimonabant) generic versions recently are introduced by Zydus Cadila, Sun Pharmaceuticals, and Torrent Pharmaceutical respectively
By: Acomplia
|
|
 |
|
 |
